In the SURMOUNT-1 trial, people treated with tirzepatide lost up to 22.5% of their body weight over 72 weeks , making it even more effective than semaglutide (NEJM tirzepatide study)
, !
5 M NaCl Tris Buffer, 2 M pH = 8.2 10% (FFA free) Bovine Serum Albumin (BSA) in dH 2 O, (Sigma, A-6003) For 50 mL no salt Krebs Ringer Phosphate (KRP) Buffer (Adjust to pH 7.4, sterile filter) (store at 4C), 3.2 mL (1.15% KCl) (10 mM), 0.5 mL (1.52% CaCl 2 2H 2 O) (1 mM), 0.16 mL (3.82% MgSO 4 7H 2 O) (1 mM), 1 mL (Phosphate Buffer, 14.2 g Na 2 HPO 4 + 20 mL 1 N HCl, dilute up to 1 L with dH 2 O, Adjust to pH 7.4) (2 mM Na 2 HPO 4 )
Serious Risks : While serious side effects from Wegovy exist, theyre rare compared to the potential neuropsychiatric effects of Contrave
Semaglutide is generally not advised for people with a history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2, among others